CIBC Private Wealth Group
URGN icon

CIBC Private Wealth Group’s UroGen Pharma URGN Stock Holding History

CIBC Private Wealth Group’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$13.5K Buy
575
+66
+13% +$1.43K ﹤0.01% 2314
2025
Q3 		$10.2K Hold
509
– – ﹤0.01% 2379
2025
Q2 		$6.97K Hold
509
– – ﹤0.01% 2371
2025
Q1 		$4.92K Hold
509
– – ﹤0.01% 2461
2024
Q4 		$5.62K Hold
509
– – ﹤0.01% 2439
2024
Q3 		$6.46K Hold
509
– – ﹤0.01% 2528
2024
Q2 		$8.2K Hold
509
– – ﹤0.01% 2359
2024
Q1 		$7.23K Buy
+509
New +$8.32K ﹤0.01% 2400

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return